AIM2 and glioblastoma: AIM2 inflammasomes scores were positively correlated with tumor mutation burden (TMB) in GBM, UVM, PCPG, UCS, KICH, LGG, READ, HNSC, THCA, KIRC, SKCM, STAD, COAD, MESO, BRCA, SARC, CESC, LIHC, KIRP, PAAD, ESCA, BLCA, UCEC, PRAD, LUSC, and OV (all P < 0.05) (Figure 12A).